Abstract: Lipid peroxidation (LPX) can play an important role in the development of pathological changes of foetal and neonatal tissues. We investigated LPX and biochemical parameters in plasma from mixed umbilical cord (m.u.c.) blood and acid-base balance (ABB) parameters in m.u.c. blood of well-adapted full-term newborns. LPX products were estimated as thiobarbituric acid reacting substances (TBARS) and were expressed by using of malondialdehyde (MDA) as a standard solution. Intensity of LPX was estimated in vitro in m.u.c. blood plasma without and with added LPX activator (125 µM L-ascorbate plus 5 µM FeSO4) and in the incubated plasma (30 min, 37
Introduction
Persistent intrauterine hypoxia could lead to damage of foetal organs, especially the brain (Wang et al. 1996) . Similarly, neonatal asphyxia is a cause of increased perinatal morbidity and mortality (Brucknerová et al. 2005) .
Previous reports pointed to the importance of mechanisms of ischemia/reperfusion injury (Lehotský & Kaplán 2003) that is induced by lipid peroxidation (LPX) in the central nervous system (Lukáčová et al. 1994) . LPX is considered to be a process which may play an important role in foetal and neonatal pathogenesis during the pathological pregnancy (Orhan et al. 2003) and the perinatal period (Kaya et al. 2000) . Although the LPX reactions are normally controlled by countervailing biochemical mechanisms, severe oxidative stress produces reactive oxygen free radicals and induces uncontrolled LPX (Kobe et al. 2002) . Newborns and especially the preterm ones are probably more prone to the oxidative stress than babies later in their life (Saugstad 2005) .
Activation of LPX in placenta (Gülmezoglu et al. 1996) , endothelial cells of umbilical cord (Wang et al. 1996) , maternal (Orhan et al. 2003) and foetal vessels (Yaacobi et al. 1999) leads to damage of these tissues with releasing of LPX products into maternal and foetal blood. LPX products, thiobarbituric acid reacting substances (TBARS) and malondialdehyde (MDA) in umbilical cord and newborn's blood, were used as indicators of foetal tissue injury caused by the perinatal hypoxia in several clinical studies Šimko et al. 2000; Brucknerová et al. 2004) . Moreover, some authors consider TBARS in umbilical cord blood as a more sensitive indicator of foetal hypoxia during labour than acid-base balance (ABB) parame- ters (Rogers et al. 1998 ). According to these facts, the aim of our study was to assess the association between LPX and biochemical parameters reflecting integrity of tissues and their supply by oxygen. LPX products were determined in plasma from mixed umbilical cord (m.u.c.) blood which was used, e.g., for study of antioxidant vitamin levels and correlated with maternal venous plasma (Baydas et al. 2002) .
It has been presented that MDA, as a minor LPX product, needs not completely reflect the extent of LPX in various biological systems (Zima et al. 1995) . That is the reason why we decided to determine total TBARS in m.u.c. blood plasma.
There have not been published any data on TBARS production in vitro in umbilical cord blood plasma under the conditions of activated LPX. Therefore, the aim of our study was not only to determine actual TBARS in m.u.c. blood plasma, but to evaluate TBARS production in vitro during experimentally activated LPX (incubation of plasma or/and addition of L-ascorbic acid and Fe 2+ ). TBARS production in vitro could help to characterize the activation of LPX completely. This entire procedure could reveal conditions and effectors which could activate LPX in plasma of healthy newborns, too. There was reported a positive association between LPX and hypoxia of newborns during labour (Rogers et al. , 1998 . The second aim of our study was therefore to measure the biochemical and ABB parameters and to assess their relationship to LPX. This could clarify whether the extent of LPX in m.u.c. blood plasma is increased with the increase of oxygen level or its decrease (hypoxia).
Subjects and methods
This study included 14 full-term newborns showing no abnormalities during delivery and no defects of adaptation after their birth (measured by Apgar score). Immediately after delivery, umbilical cord was doubly clamped and the m.u.c. blood was obtained from the artery and vein into heparin-coated glass tubes. All blood samples were collected at the Subdepartment of Maternal-Foetal Medicine, Faculty of Medical Specialty Studies, Slovak Medical University in Bratislava. The samples were analysed for ABB parameters (pH, pCO2, pO2, base excess (BE) and bicarbonate (HCO − 3 )). Plasma from the m.u.c. blood was used for determination of LPX products and further biochemical analyses. Biochemical parameters: iron, total iron-binding capacity (TIBC), uric acid, total proteins, magnesium, calcium, inorganic phosphate, glucose, potassium, sodium, chlorides and activities of enzymes: alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), γ-glutamyltransferase (GMT), lactate dehydrogenase (LD), α-hydroxybutyrate dehydrogenase (HBD = isoenzyme LD1 and LD2), α-amylase (AMS) and alkaline phosphatase (ALP), were measured by routine biochemical methods. The activities of enzymes were determined at 37
• C. All analyses were performed at the Clinic of Laboratory Medicine, Dérer Medical Faculty Hospital in Bratislava.
LPX was investigated in vitro in m.u.c. blood plasma in the 4 following experimental situations: (i) in non-incubated plasma without added LPX activator (0-A) which represents the actual levels of LPX products; (ii) in nonincubated plasma with the added LPX activator (its concentration in incubation mixture was 125 µM L-ascorbic acid plus 5 µM FeSO4) (0+A) which can help to assess the intensity of LPX and presence of antioxidants; (iii) in incubated plasma (30 min, 37
• C) without the added LPX activator (30-A) which might provide information on development of LPX and formation of its products as well as on the presence of antioxidant and prooxidant factors; and (iv) in incubated plasma with the added LPX activator (30+A) which might provide information on the presence of suitable LPX substrates and on relation between prooxidant and antioxidant factors.
LPX products were estimated by TBARS method described by Ohkawa et al. (1979) , with some modifications. All the plasma samples were adjusted to pH 7.4 by buffer solution Tris-HCl (8.3 mM). Half of the samples were incubated without or with the added LPX activator for 30 min at 37
• C. After addition of 2% (v/v) H3PO4 and 0.6% (w/v) thiobarbituric acid (TBA), all samples were boiled for 45 min at 100
• C. The produced TBARS were extracted with n-butanol. After centrifugation (10 min, 3000 r.p.m.) the absorbance of the upper n-butanol layer was measured spectrophotometrically at 532 nm. Although various LPX products react with TBA, except for MDA, the precursor of MDA (1,1,3,3-tetraethoxypropane) was used for TBARS determination as a commonly utilised standard solution (Yagi 1993; Malamitsi-Puchner et al. 1998; Rogers et al. 1999) . TBARS concentrations were calculated from the standard curve of MDA and expressed as nmol/mL of plasma.
All results were presented as means ± standard error of the mean (SEM). For statistical analysis, Mann Whitney U test for a pair-wise comparison and Spearman's rank correlation test (two-tailed analysis) were used. A value of p < 0.05 was considered to be statistically significant. Table 1 summarizes the clinical characteristics of the newborns included in this study. All of the newborn weights were appropriate to the gestational age.
Results
TBARS determined in m.u.c. blood plasma of term newborns are shown in Fig. 1 . Approximately two times higher TBARS formation (marginally significant, p = 0.057) was observed in non-incubated plasma with the added LPX activator (0+A) in comparison with actual TBARS (non-incubated plasma without added LPX activator = 0-A). Almost the same TBARS production was found in incubated plasma without (30-A) and with the added LPX activator (30+A), in comparison with the non-incubated plasma with the added LPX activator (0+A). Moreover, Figure 1 includes TBARS determined in m.u.c. blood plasma of one chosen newborn (newborn "N") which had the most considerably changed ABB parameters in the m.u.c. blood. In each experimental situation, TBARS observed in this newborn's m.u.c. blood plasma were approximately three times higher than TBARS of the complete group.
Biochemical parameters analysed in m.u.c. blood plasma were within reference ranges published for umbilical cord serum or serum of newborns, except for higher TIBC and lower AST and HBD activities (Tab. 2). Similarly, these parameters analysed in m.u.c. blood plasma of the newborn "N" were within these reference ranges, except for lower iron, potassium, chlorides and AST which were also lower in comparison with the total group. All ABB parameters analysed in m.u.c. blood were within the reference ranges for umbilical cord blood of newborns (Tab. 3). Table 3 includes also ABB parameters in m.u.c. blood of the newborn "N", who had the lowest pH and BE from the complete group.
The actual TBARS levels (0-A) in m.u.c. blood plasma were found being positively correlated with HBD activity (r = +0.83, p < 0.05) and negatively 
Discussion
The actual TBARS values (3.51 ± 0.49 nmol/mL) determined in m.u.c. blood plasma were similar to TBARS (3.96 nmol/mL) in serum of healthy term newborns on the 2 nd -4 th day of life (Metsvaht et al. 1999 ). Taking into account that all the monitored newborns were well adapted (Tab. 1), we consider our TBARS levels as physiological TBARS in m.u.c. blood plasma.
MDA is considered to be the end product of LPX which reacts with TBA, although there are also other LPX products reacting with TBA in plasma. This is the reason, why we used TBARS as indicator of the total extent of LPX in umbilical cord plasma, similarly to other authors (Wang et al. 1996; Rogers et al. 1998; Tao et al. 2003) . The higher actual TBARS measured in the complete m.u.c. blood plasma might include larger spectrum of LPX products reacting with TBA than TBARS measured by Yagi (1993) in precipitated plasma proteins and lipoproteins of children (2.08 nmol/mL).
The higher TBARS formation in vitro in m.u.c. blood plasma in all experimental situations (Fig. 1) , if compared with actual TBARS in this plasma, refers to activation of LPX by incubation, addition of LPX activator or both together. Similarly, the positive correlation between actual TBARS and their formation in this plasma with the added LPX activator suggests this activation. However, addition of the LPX activator did not increase TBARS formation in incubated plasma if compared with TBARS formation in incubated plasma without this addition. It could indicate that TBARS production in m.u.c. blood plasma could be limited by sufficient amounts of LPX substrates in this plasma. On the other hand, the positive correlation between TBARS formation in incubated plasma with the added LPX activator versus TBARS in incubated plasma without it (Fig. 1) suggests suitable conditions for LPX in m.u.c. blood plasma. These conditions could reflect the low total plasma antioxidant capacity which is negatively correlated with TBARS in the plasma of newborns (Metsvaht et al. 1999) .
The positive correlation was found between actual TBARS levels and HBD activity in m.u.c. blood plasma and the negative correlation between actual TBARS levels and pO 2 in this m.u.c. blood. HBD is considered to be one of the parameters reflecting damage of tissue by hypoxia (Masopust 1998) . These results might indicate that TBARS formation in plasma from m.u.c. blood is more related to the development of hypoxia than to the presence of oxygen. This notion is supported also by parameters analysed in m.u.c. blood plasma of one chosen newborn "N". We observed three times higher actual TBARS as well as TBARS formation in the m.u.c. blood plasma of this newborn "N" (Fig. 1) in comparison with the complete group. At the same time, the most considerably changed ABB parameters indicating hypoxia (mainly pH and BE) were measured in "N" m.u.c. blood (Tab. 3). These results could suggest the activation of LPX in m.u.c. blood plasma in conditions of hypoxia. Additionaly, Buonocore et al. (1998) reported a view that just perinatal hypoxia caused intraerythrocyte free iron release and induction of LPX in plasma of newborns. Based on these facts and our results, we assume that TBARS could be a suitable parameter of LPX extent in umbilical cord plasma of newborns.
Biochemical parameters reflect a physiological and nutritional status of an organism, not only of an adult but of a newborn, too (Poláček et al. 1981; Cowett 1991) . It is known that these parameters are changed depending on the age of the organism. We found a lower TIBC (42.08 ± 6.38 µmol/L) in m.u.c. blood plasma than TIBC (86.08 ± 4.34 µmol/L) in maternal venous post-delivery plasma (Maceková et al. 2000) . Our results are in agreement with Masopust (1998) , who reported that TIBC in plasma of newborns could be approximately by 30% lower than TIBC in plasma of adults. Two findings of our study: (i) the lower TIBC and (ii) the higher TBARS formation in m.u.c. blood plasma in comparison with maternal venous plasma (Maceková et al. 2000) suggest a possible significance of free iron in m.u.c. blood plasma which could be an activating factor of LPX. Additionally, Moison et al. (1993) found that non-protein-bound iron was not detected in plasma of adults but it was present in plasma of term babies. Tao et al. (2003) presented significantly higher TBARS in plasma of asphyxiated newborns as well as approximately 3-times higher amount of nonprotein-bound iron in their plasma in comparison with healthy individuals.
In conclusion, our results suggest that LPX in umbilical cord plasma of term well-adapted newborns might be activated. This activation could probably reflect the extent of hypoxia rather than presence of oxygen. The actual TBARS levels and their in vitro formation in experimental conditions with using of LPX activator (L-ascorbic acid and iron) could be suitable parameters of extent of LPX in umbilical cord plasma of newborns.
